ArticleJournal of managed care & specialty pharmacy2021
Budget impact analysis of niraparib for first-line maintenance therapy in advanced ovarian cancer from a US payer perspective.
Jinan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.